Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,040 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DUPAN-II normalisation as a biological indicator during preoperative chemoradiation therapy for resectable and borderline resectable pancreatic cancer.
Hasegawa S, Takahashi H, Akita H, Mukai Y, Mikamori M, Asukai K, Yamada D, Wada H, Fujii Y, Sugase T, Yamamoto M, Takeoka T, Shinno N, Hara H, Kanemura T, Haraguchi N, Nishimura J, Matsuda C, Yasui M, Omori T, Miyata H, Ohue M, Ishikawa O, Sakon M. Hasegawa S, et al. Among authors: akita h. BMC Cancer. 2023 Jan 18;23(1):63. doi: 10.1186/s12885-023-10512-2. BMC Cancer. 2023. PMID: 36653747 Free PMC article.
The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
Higashiguchi M, Murakami H, Akita H, Kobayashi S, Takahama S, Iwagami Y, Yamada D, Tomimaru Y, Noda T, Gotoh K, Doki Y, Yamamoto T, Eguchi H. Higashiguchi M, et al. Among authors: akita h. Oncol Rep. 2023 May;49(5):98. doi: 10.3892/or.2023.8535. Epub 2023 Mar 31. Oncol Rep. 2023. PMID: 36999632 Free PMC article.
Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer: Long-term Conditional Recurrence-free Survival Analysis in the Setting of a Neoadjuvant Treatment Strategy.
Takahashi H, Akita H, Wada H, Miyata H, Eguchi H, Ohigashi H, Sakon M, Ishikawa O. Takahashi H, et al. Among authors: akita h. Ann Surg. 2023 Dec 1;278(6):e1216-e1223. doi: 10.1097/SLA.0000000000005879. Epub 2023 Apr 14. Ann Surg. 2023. PMID: 37057622
SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
Takayama H, Kobayashi S, Gotoh K, Sasaki K, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Asaoka T, Noda T, Wada H, Takahashi H, Tanemura M, Doki Y, Eguchi H. Takayama H, et al. Among authors: akita h. J Cancer Res Clin Oncol. 2023 Sep;149(12):10935-10950. doi: 10.1007/s00432-023-04835-7. Epub 2023 Jun 17. J Cancer Res Clin Oncol. 2023. PMID: 37330435
Long-Term Feasibility of Rescue Reconstruction for Isolated Bile Ducts With Using Cystic Duct in Living Donor Liver Transplantation.
Kubo M, Tomimaru Y, Gotoh K, Kobayashi S, Marukawa D, Sasaki K, Iwagami Y, Yamada D, Akita H, Noda T, Takahashi H, Asaoka T, Tanemura M, Marubashi S, Nagano H, Dono K, Doki Y, Eguchi H. Kubo M, et al. Among authors: akita h. Transplant Proc. 2023 Sep;55(7):1611-1617. doi: 10.1016/j.transproceed.2023.03.086. Epub 2023 Jun 28. Transplant Proc. 2023. PMID: 37385837 Free article.
Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma.
Nishi H, Gotoh K, Tomimaru Y, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, Akita H, Asaoka T, Noda T, Takahashi H, Tanemura M, Doki Y, Eguchi H. Nishi H, et al. Among authors: akita h. Cancer Chemother Pharmacol. 2023 Oct;92(4):303-314. doi: 10.1007/s00280-023-04531-w. Epub 2023 Jul 26. Cancer Chemother Pharmacol. 2023. PMID: 37491611 Free PMC article.
ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radiological Response to Neoadjuvant Treatment for Pancreatic Cancer.
Miyahara S, Takahashi H, Akita H, Sasaki K, Mukai Y, Iwagami Y, Hasegawa S, Yamada D, Tomimaru Y, Noda T, Wada H, Kobayashi S, Doki Y, Eguchi H. Miyahara S, et al. Among authors: akita h. Ann Surg Oncol. 2024 May;31(5):2971-2972. doi: 10.1245/s10434-024-15021-5. Epub 2024 Feb 16. Ann Surg Oncol. 2024. PMID: 38363472 No abstract available.
Prognostic Significance of Biologic Factors in Patients with a Modest Radiologic Response to Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancers: Impact of the Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers.
Miyahara S, Takahashi H, Akita H, Sasaki K, Mukai Y, Iwagami Y, Hasegawa S, Yamada D, Tomimaru Y, Noda T, Wada H, Kobayashi S, Doki Y, Eguchi H. Miyahara S, et al. Among authors: akita h. Ann Surg Oncol. 2024 May;31(5):2932-2942. doi: 10.1245/s10434-024-14945-2. Epub 2024 Feb 17. Ann Surg Oncol. 2024. PMID: 38368291
1,040 results